MediLumine’s Mvivo Au contrast agent was injected at a dose of 0.1 ml in nude mice grafted with Sdhb(-/-) and scanned with Mediso nanoScan PET/CT at Inserm U970, Paris, France (Viel T, Yoganathan T, Perez-Liva M, Tavitian B). 3D CT images of tumor vasculature were generated with Amira 3D visualization and analysis software for life sciences (Thermo Fisher Scientific).

MediLumine Expands Imaging Reagent Portfolio Through Collaboration with Luminicell
MediLumine is pleased to announce a new distribution partnership with Luminicell, enabling researchers to access the Cellaris™ Cell Labelling Kit and Vascular Tracker™ Labelling Kit